Skip to main content
. Author manuscript; available in PMC: 2023 Feb 24.
Published in final edited form as: J Med Chem. 2022 Feb 4;65(4):3644–3666. doi: 10.1021/acs.jmedchem.1c02165

Figure 4.

Figure 4.

Effects of compounds 2441 on reducing the AKT protein level and inhibiting the downstream signaling. BT474 cells were treated with AZD5363 (1 μM), POM (1 μM), or indicated compound at 1, 5, and 10 μM for 24 h. The cell lysates were analyzed by western blotting to examine the protein levels of T-AKT, P-AKT (S473), P-PRAS40 (T246), and P-S6 (S240/244). β-Actin was used as the loading control.